At In the Pipeline, Derek Lowe makes a good point about the current state of outsourcing large-scale chemical production work to today's cheaper economies, like China and India:  it's not going to go away and medicinal chemists need to start expanding their idea of what it means to be a good drug discoverer. Generating ideas, doing harder chemistry, and offering top-notch communication and collaboration skills are part of it, he says.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.